Pharmacogenomics, drug development, and ethics: Some points to consider

Drug Development Research

Volumn 62, Issue 2, 2004, Pages 112-116

  Lunshof, Jeantine ^a   De Wert, Guido ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Clinical research; Ethics; Genetic exceptionalism; Pharmacogenomics; Points to consider; Stratification

Indexed keywords

CLINICAL RESEARCH; DRUG DEVELOPMENT; DRUG RESEARCH; FOOD AND DRUG ADMINISTRATION; HEALTH CARE POLICY; HUMAN; INFORMED CONSENT; PHARMACOGENOMICS; REVIEW; RISK ASSESSMENT; VOLUNTEER;

EID: 9644254344     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10373     Document Type: Review

References (33)

1. Anderlik MR. 2003. Commercial biobanks and genetic research. Am J Pharmacogenomics 3:203-215.
2. The Belmont Report. 1979. National Commission for the Protection of Human Subjects in Biomedical and Behavioral Research. Washington, D.C.: DHEW Publications.
3. Buchanan A, Califano A, Kahn J, McPherson E, Robertson J, Brody B. 2002. Pharmacogenetics: ethical issues and policy options. Kennedy Inst Ethics J 12:1-15.
4. Burchard EG, Ziv E, Coyle N, Gomez SL, Tang H, Karter AJ, Mountain JL, Perez-Stable EJ, Sheppard D, Risch N. 2003. The importance of race and ethnic background in biomedical research and clinical practice. N Engl J Med 348:1170-1175.
5. Cassell EJ. 2000. The principles of the Belmont Report revisited: how have respect for persons, beneficence, and justice been applied to clinical medicine? Hastings Center Rep 30:12-21.
6. Council of Europe. 2003. Council of Europe Working Party on Human Genetics. Working document on the applications of genetics for health purposes. (CDBI-CO-GT4). http://www.coe.int/T/E/Legal_affairs/Legal_co-operation/ Bioethics/Activities/Human_genetics
7. The Declaration of Helsinki. 1964. World Medical Association Declaration of Helsinki. Edinburgh, 2000.
8. http://www.wma.net/ethicsunit/helsinki.htm
9. Emanuel EJ, Wendler D, Grady C. 2000. What makes clinical research ethical? JAMA 283:2701-2711.
10. European Commission. 2004a. European Commission Expert Group. Ethical, legal and social aspects of genetic testing: research, development and clinical applications. Brussels: European Commission.
11. http://europa.eu.int/comm/research/conferences/2004/genetic/report_en.htm
12. European Commission. 2004b. European Commission Expert Group. 25 Recommendations on the ethical, legal and social implications of genetic testing. Brussels: European Commission.
13. http://europa.eu.int/comm/research/conferences/2004/genetic/ recommendations_en.htm
14. Evans WE, Relling MV. 2004. Moving towards individualized medicine with pharmacogenomics. Nature 429:464-468.
15. FDA. 2003. Food and Drug Administration document: Collection of Race and Ethnicity Data in Clinical Trials; Draft Guidance for Industry.
16. http://www.fda.gov./cder/guidance/5054dft.pdf
17. Gurwitz D, Weizman A, Rehavi M. 2003. Education: teaching pharmacogenomics to prepare future physicians and researchers for personalized medicine. Trends Pharmacol Sci 24:122-125.
18. Haga SB, Venter CJ. 2003. FDA races in wrong direction. Science 301:466.
19. Kerwin RW. 2003. A perspective on progress in pharmacogenomics. Am J Pharmacogenoms 3:371-373.
20. Knoppers BM. 2000. Population genetics and benefit sharing. Commun Genet 3:212-214.
21. Nebert DW, Jorge-Nebert L, Vesell ES. 2003. Pharmacogenomics and individualized drug therapy: high expectations and disappointing achievements. Am J Pharmacogenom 3:361-370.
22. Norton RM. 2001. Clinical pharmacogenomics: applications in pharmaceutical R&D. Drug Discov Today 6:180-185.
23. Nuffield Council on Bioethics. 1993. Genetic screening: ethical issues. London.
24. http://www.nuffieldbioethics.org/geneticscreening/index.asp
25. Nuffield Council on Bioethics. 2003. Pharmacogenetics: ethical issues. London.
26. http://www.nuffieldbioethics.org/pharmacogenetics/latestnews.asp
27. Nuremberg Code. 1949. Trials of war criminals before the Nuremberg Military Tribunals under Control Council Law, 1949. Washington, DC: U.S. Government Printing Office. p.181-182.
28. Page GP, George V, Go RC, Page PZ, Alison DB. 2003. "Are we there yet?": Deciding when one has demonstrated specific genetic causation in complex disease and quantitative traits. Am J Hum Genet 73:711-719.
29. Screening and Counseling for Genetic Conditions. 1983. President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. Washington, D.C.: U.S. Government Printing Office.
30. Suter SM. 2001. The allure and peril of genetics exceptionalism: do we need special genetics legislation? Washington Univ Law Q 79:669-748.
31. UNESCO. 2003. International Declaration on Human Genetic Data. Paris: UNESCO.
32. http://unesdoc.unesco.org/images/0013/001342/134217e.pdf
33. WHO. 2003. World Health Organization. Wertz DC, Fletcher JC, Berg K, editors. Review of ethical issues in medical genetics. Geneva: WHO